Key Highlights

  • SHF Holdings rose 44.89% to USD 0.0326 in Friday trading on November 13, 2026, according to market data, which implies a prior close of about USD 0.0225 (calculated) that may not be reliable.
  • Eight consecutive business-day closes under USD 0.10 have been recorded, and a tenth would set off a Nasdaq delisting determination, according to the company's letter of November 9, 2026.
  • Common shares outstanding climbed from about 1.03 million on September 30 to roughly 132.2 million on November 6, 2026, as Series B preferred conversions added about 131.2 million shares.
  • Third quarter 2026 Revenue reached USD 1.95 million, up 6.5%, while the net loss was about USD 0.98 million and the financial statements carry a Going Concern disclosure.

A Rebound From Lows Below USD 0.10, Cause Unconfirmed

SHF Holdings (NASDAQ:SHFS) gained 44.89% to USD 0.0326 on Friday, November 13, 2026, per market data. Nothing dated November 11 to 13 from the company has been found that accounts for the rise. The company, which trades as Safe Harbor, provides financial services to businesses tied to cannabis. A rebound from such a low level carries little weight by itself, since a few trades can shift the quote, spreads may be wide, gains can fade, and the implied prior close of about USD 0.0225 is a calculation. The November 9 letter notes that trading has been mostly under USD 1.00 since the split, and that management could ask for approval of a further reverse split.

Preferred Conversions and the Opifex Term Sheet

A 1-for-12 reverse split became effective on September 30, 2026. On October 22 the Series B conversion price fell from USD 18.6336 to USD 0.1210, and holders had converted 19,529 Series B shares into roughly 131.2 million common shares by November 6. Another 7,605 Series B shares remain convertible into as many as about 62.9 million more. On October 23, SHF Holdings (NASDAQ:SHFS) entered a nonbinding term sheet with Opifex Media, a creator-economy company, under which Opifex holders would hold about 85% and legacy holders about 15%, with the split adjustable between 12.5% and 17.5%. Closing requires definitive agreements, a fairness opinion, stockholder and Nasdaq sign-off, and there is no guarantee the deal completes.

Compliance Deadline, Abaca Case and Equity Cushion

Nasdaq has granted a second 180-day compliance window that runs through April 19, 2027, and the shares must trade at or above USD 1.00 for ten straight Business days. Stockholders' equity was USD 5.2 million on September 30, comfortably over the USD 2.5 million floor. In the Abaca case, a trial was held on August 10 and 11, 2026 without a ruling so far, and the company puts a reasonably possible loss at USD 0 to USD 7.8 million plus interest. SHF Holdings (NASDAQ:SHFS) raised USD 1.1 million through its equity line over the first nine months and does not plan to draw further while the term sheet stands.

Where Things Stand

Nothing confirmed accounts for the 44.89% increase. SHF Holdings (NASDAQ:SHFS) bounced off a quote below USD 0.10, but heavy Series B conversions, a pending Opifex term sheet and a Nasdaq bid price shortfall are still unresolved. Ten closes under USD 0.10 would lead to a delisting determination, so the price path matters. Next signposts include a definitive Opifex agreement, a possible vote on another reverse split and any ruling in the Abaca case.